About Us President's Letter Mission Statement Our Origins Goals & Standards Board of Directors Curriculum Committee Continuing Education Committee Privacy Policy Complete List of Courses Open Enrollment Courses In-House Courses Distance Education Courses Webinars   NEW Pharmaceutical Medicine Certificate Programs Career Planning Our Faculty Become PERI Faculty     About Us    |    Opportunities    |    Mailing List    |    Contact Us    |    Search    |    Home   Curriculum Committee Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP Professor and Chairman Department of Pharmacotherapy College of Pharmacy Washington State University Noel J. Cusack, PhD Vice President Chief Scientific Officer Aderis Pharmaceuticals Nancy L. Durst-Clementi, MD Vice President for Medical Communication Global Medical Affairs Wyeth-Ayerst Pharmaceuticals Marcia D. Garb, MSc Director, Education & Training Clinical and Regulatory Development Merck & Co., Inc. David I. Goldsmith, MD President, Senior Consultant Goldsmith Pharmacovigilance & Systems Charles V. Grudzinskas, PhD Drug Development Consultant Steven A. Hamburger, PhD Senior Director Global Regulatory Strategic Leader Oncology Johnson & Johnson Pharmaceutical Research & Development, LLC Layne M. Johnson, PhD Senior Director Global Information Networks Pharmacia Thomas J. Ott, BA Director Worldwide Regulatory Compliance Bristol-Myers Squibb Pharmaceutical Research Institute Anthony J. Piraino, MD, PhD Director Clinical Pharmacology and Clinical Research Respiratory AstraZeneca, LP Cheryl J. Priest, RN Independant Clinical Development Training and Quality Process Consultant   R. Richard Rhodes Retired Senior Director Project Management DuPont Merck Pharmaceutical Company Barry Sagotsky, MBA Senior Vice President Director Clinical Trial Recruitment GCI Group Hugh H, Tilson, MD, DrPH Senior Advisor to the Dean Clinical Professor of Epidemiology and Health Policy School of Public Health University of North Carolina